GlassScriptPhysician profile
Edward G Baptista
NPI 1487762209
$15,966.79
in general payments reported to CMS, 2019-2025
53 companies · $2,003 in 2025
The $2,003 reported for 2025 was more than what 83% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,443 · 2020: $2,323 · 2021: $2,352 · 2022: $2,370 · 2023: $2,516 · 2024: $1,959 · 2025: $2,003.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,381 · Education: $97.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,381.21 |
| Education | $97.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,990.75 | 2019-2025 | |
| Boston Scientific Corporation | $1,943.78 | 2019-2025 | Watchman Flx, Watchman Access System |
| Abbott Laboratories | $1,663.84 | 2019-2025 | Aveir, Advisor, Ensite Precision |
| E.R. Squibb & Sons, L.L.C. | $770.70 | 2019-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $710.35 | 2021-2025 | Verquvo, Steglatro, Steglujan |
| Janssen Pharmaceuticals, INC | $706.76 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $647.54 | 2020-2025 | Lifevest |
| Amgen INC. | $595.13 | 2019-2024 | Repatha |
| Esperion Therapeutics, INC. | $588.08 | 2020-2025 | Nexletol |
| Bard Peripheral Vascular, INC. | $567.98 | 2019-2022 | |
| Amarin Pharma, INC. | $555.04 | 2019-2022 | |
| Cvrx, INC. | $443.11 | 2021-2025 | Barostim Neo System |
| Pfizer INC. | $436.81 | 2019-2024 | |
| Tactile Systems Technology INC | $371.95 | 2019-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Impulse Dynamics (USA) INC. | $357.84 | 2021-2023 | Optimizer |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $354.07 | 2024-2025 | Assure Wcd |
| Astrazeneca Pharmaceuticals LP | $310.64 | 2019-2025 | Wainua, Farxiga, Brilinta |
| Astellas Pharma US INC | $304.87 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $292.28 | 2019-2023 | |
| Heartflow, INC. | $262.08 | 2019-2025 | |
| Novo Nordisk INC | $228.86 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Actelion Pharmaceuticals US, INC. | $174.18 | 2019-2024 | Opsumit, Uptravi |
| Biotronik INC. | $160.62 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $154.82 | 2019-2025 | Jardiance |
| Kowa Pharmaceuticals America, INC. | $144.39 | 2019-2022 | |
| Cardiovascular Systems INC. | $108.33 | 2019-2020 | |
| Bridgebio Pharma, INC. | $102.38 | 2025 | Attruby |
| Canon Medical Systems USA, INC. | $98.86 | 2023 | Pet-Ct Scanner |
| Atricure, INC. | $84.06 | 2022-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Angiodynamics, INC. | $83.31 | 2025 | Alphavac |
| Alnylam Pharmaceuticals INC. | $69.80 | 2021-2023 | Onpattro |
| Bolton Medical INC | $65.63 | 2020 | |
| Regeneron Pharmaceuticals, INC. | $64.92 | 2019-2025 | Evkeeza |
| Medtronic, INC. | $60.62 | 2022-2023 | Inpen Smart Insulin Delivery System |
| Medicure Pharma INC. | $49.91 | 2021-2022 | |
| Zoll Circulation INC | $36.94 | 2020-2022 | |
| Biosense Webster, INC. | $34.11 | 2023 | Carto 3 |
| Tandem Diabetes Care, INC. | $33.17 | 2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Regeneron Healthcare Solutions, INC. | $32.37 | 2019 | |
| Biom'Up France Sas | $31.78 | 2020 | |
| Endologix LLC | $30.94 | 2021 | |
| Argon Medical Devices, INC. | $28.85 | 2025 | Clot Management |
| Kiniksa Pharmaceuticals International, Plc | $28.67 | 2024 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $28.67 | 2023 | Inpefa |
| Arbor Pharmaceuticals, INC. | $28.07 | 2019-2020 | |
| Resmed Corp | $25.10 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.61 | 2025 | |
| Recor Medical INC | $16.20 | 2025 | Paradise Ultrasound Renal Denervation System |
| Medtronic Vascular, INC. | $14.90 | 2019 | |
| Lilly USA, LLC | $14.63 | 2022 | |
| Lemaitre Vascular, INC. | $13.96 | 2019 | |
| Becton, Dickinson and Company | $13.39 | 2024 | Rotarexs 6 F X 135 Cm |
| Altathera Pharmaceuticals LLC | $12.14 | 2023 | Sotalol Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Baptista listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.